Business
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors GlobeNewswire March 28, 2024 VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq:
GlobeNewswire
March 28, 2024
VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to its board of directors effective April 2, 2024.
